Prospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 16, 2023; 11(23): 5479-5493
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5479
Table 1 Optical coherence tomography angiography measurements of health students in Qamdo divided into habitat distribution which include mean foveal thickness, foveal avascular zone area, and vascular plexus density

Karuo (n = 28)
Dengqen (n = 38)
Markam (n = 48)
Chagyab (n = 48)
P value
AL, mm22.71 ± 0.5122.94 ± 0.7522.92 ± 0.7823.02 ± 0.580.0346
Foveal thickness, μm243.00 ± 21.00233.42 ± 22.31235.24 ± 15.23228.18 ± 17.620.0075
FAZ, mm20.26 ± 0.120.32 ± 0.100.26 ± 0.100.32 ± 0.110.0211
FVD, mm-120.40 ± 2.0520.78 ± 1.7820.24 ± 1.5820.72 ± 1.450.2626
IVD, mm-121.55 ± 2.1622.17 ± 1.5621.34 ± 1.7021.66 ± 1.700.6049
CVD, mm-110.07 ± 3.4210.59 ± 3.6910.99 ± 3.759.34 ± 3.010.1211
cFoveal thickness, μm226.31 ± 20.40217.49 ± 18.10221.81 ± 19.81218.46 ± 22.060.0075
cFAZ, mm20.26 ± 0.110.28 ± 0.090.24 ± 0.090.29 ± 0.100.1811
cFVD, mm-118.33 ± 2.1819.48 ± 1.7018.89 ± 1.7519.30 ± 1.570.0532
cIVD, mm-119.49 ± 2.3420.69 ± 1.8621.34 ± 1.7021.66 ± 1.700.0379
cCVD, mm-19.26 ± 2.8510.12 ± 3.3610.13 ± 3.139.53 ± 3.230.5612
Table 2 Clinical characteristics of the study samples and optical coherence tomography measurements of retinal and subfoveal choroidal thickness according to sex

ALL (n = 347)
Girls (n = 182)
Boys (n = 165)
P value
Age, yr10.62 ± 2.82 (range 5-18)10.70 ± 2.8410.53 ± 2.800.0781
Vision4.78 ± 0.304.74 ± 0.334.83 ± 0.260.1043
AL, mm23.31 ± 1.0123.53 ± 0.8923.10 ± 1.08< 0.0001
SE, diopters-0.88 ± 1.40-0.96 ± 1.60-0.79 ± 1.140.4601
Mean foveal thickness239.81 ± 19.13238.44 ± 20.13241.33 ± 17.910.0097
FAZ, mm20.29 ± 0.130.30 ± 0.120.28 ± 0.140.0119
FVD, mm-120.38 ± 1.8820.31 ± 1.8520.45 ± 1.920.0210
IVD, mm-121.65 ± 1.9222.50 ± 12.2621.72 ± 1.910.0610
CVD, mm-110.43 ± 3.7910.38 ± 4.0410.49 ± 3.530.7800
cMean foveal thickness227.64 ± 23.51227.30 ± 21.87228.73 ± 24.970.0863
cFAZ, mm20.27 ± 0.120.27 ± 0.100.28 ± 0.130.0029
cFVD, mm-119.35 ± 20919.38 ± 2.0919.32 ± 2.120.7931
cIVD, mm-121.00 ± 8.2921.49 ± 11.9320.58 ± 2.150.3343
cCVD, mm-19.93 ± 3.7010.28 ± 3.889.49 ± 3.390.0513
Table 3 Clinical characteristics of the study samples and optical coherence tomography measurements of retinal and subfoveal choroidal thickness according to ages

5 (n = 2)
6 (n = 20)
7 (n = 40)
8 (n = 33)
9 (n = 35)
10 (n = 39)
11 (n = 36)
12 (n = 38)
13 (n = 43)
14 (n = 36)
15 (n = 15)
≥ 16 (n = 10)
P value
F:M0.0013890.4645830.8881940.7604170.7618060.8465280.6395830.9277780.931250.76250.4611110.252778
Vision4.90 ± 0.074.90 ± 0.194.90 ± 0.054.90 ± 0.084.89 ± 0.184.78 ± 0.294.72 ± 0.294.66 ± 0.344.73 ± 0.364.59 ± 0.364.60 ± 0.324.67 ± 0.37< 0.0001
AL, mm22.34 ± 0.7722.54 ± 0.6622.64 ± 0.6723.02 ± 0.8222.97 ± 0.7523.11 ± 1.0623.73 ± 0.7723.70 ± 1.0423.54 ± 0.9923.98 ± 1.0624.08 ± 0.7624.59 ± 1.63< 0.0001
MFT, μm212.00 ± 2.83216.18 ± 13.22232.08 ± 15.00235.77 ± 15.24242.47 ± 15.36248.04 ± 14.05242.94 ± 14.59236.35 ± 17.29242.75 ± 20.62249.40 ± 26.93243.62 ± 16.51233.67 ± 10.500.00097
FAZ, mm20.64 ± 0.900.34 ± 0.130.30 ± 0.110.31 ± 0.130.30 ± 0.110.25 ± 0.100.28 ± 0.1200.32 ± 0.120.26 ± 0.130.30 ± 0.080.32 ± 0.090.31 ± 0.170.008
FVD, mm-115.80 ± 0.919.90 ± 1.5720.51 ± 1.3920.45 ± 2.1920.62 ± 0.9021.02 ± 1.6320.40 ± 1.6620.68 ± 1.5020.27 ± 2.2320.65 ± 1.5520.62 ± 1.5821.83 ± 1.180.04549
IVD, mm-117.20 ± 1.2721.35 ± 1.6821.91 ± 1.3021.84 ± 2.1821.91 ± 0.9922.22 ± 1.6121.70 ± 1.6922.18 ± 1.4421.65 ± 2.2222.00 ± 1.5622.00 ± 1.5123.23 ± 0.76< 0.0001
CVD, mm-15.30 ± 0.998.58 ± 2.789.67 ± 3.049.44 ± 3.3310.36 ± 2.6111.68 ± 3.0110.22 ± 2.688.95 ± 2.709.52 ± 3.5110.05 ± 2.739.61 ± 3.1010.83 ± 4.31< 0.0001
cMFT, μm215.700 ± 3.456216.14 ± 23.13217.53 ± 22.41217.45 ± 39.31231.87 ± 22.93233.82 ± 20.25233.96 ± 18.59236.02 ± 25.43235.73 ± 26.33219.88 ± 25.95224.18 ± 30.12223.87 ± 31.330.0012
cFAZ, mm20.46 ± 0.230.32 ± 0.080.24 ± 0.130.25 ± 0.080.24 ± 0.110.26 ± 0.110.30 ± 0.100.31 ± 0.110.26 ± 0.090.28 ± 0.090.39 ± 0.350.20 ± 0.110.0026
cFVD, mm-117.62 ± 0.8718.79 ± 1.4718.78 ± 2.5918.89 ± 1.9719.45 ± 2.1619.49 ± 2.1419.83 ± 1.7319.93 ± 2.1219.74 ± 2.0819.12 ± 1.8918.93 ± 2.5718.81 ± 2.720.01862
cIVD, mm-119.26 ± 0.4520.05 ± 1.4619.92 ± 2.6720.02 ± 3.9620.57 ± 2.1520.70 ± 2.2121.11 ± 1.8421.22 ± 2.0621.02 ± 2.1120.32 ± 2.0520.16 ± 2.4220.17 ± 2.630.01886
cCVD, mm-15.08 ± 3.238.87 ± 3.189.95 ± 3.9310.32 ± 3.5110.77 ± 4.1310.07 ± 3.739.90 ± 3.269.95 ± 4.889.71 ± 2.749.53 ± 3.159.25 ± 4.008.33 ± 4.170.02676
Table 4 Quantitative analysis and the linear regression analyses in optical coherence tomography angiography scans according to age after correction

Equation
F
P value

ALY = 0.1522 × X + 21.6179.59< 0.0001Significant
CVDY = 0.1907 × X + 7.8517.9740.005Significant
IVDY = 0.2350 × X + 17.9137.71< 0.0001Significant
FVDY = 0.2137 × X + 16.960.08468< 0.0001Significant
FAZY = 0.0003520 × X + 0.27100.020860.8853Not significant
MFTY = 3.549 × X + 188.079.81< 0.0001Significant
Table 5 Clinical characteristics of the study samples and optical coherence tomography measurements of retinal and subfoveal choroidal thickness according to different area

Karuo (n = 83)
Dengqen (n = 69)
Markam (n = 67)
Chagyab (n = 76)
P value
Vision4.64 ± 0.334.80 ± 0.264.88 ± 0.254.84 ± 0.28< 0.0001
AL, mm23.59 ± 1.1023.22 ± 0.9323.15 ± 1.0123.22 ± 0.930.007
Mean Foveal Thickness, μm248.93 ± 13.53236.35 ± 21.37239.24 ± 15.46236.11 ± 20.23< 0.0001
FAZ, mm20.30 ± 0.160.29 ± 0.110.27 ± 0.100.29 ± 0.110.604
FVD, mm-120.40 ± 2.0520.78 ± 1.7920.25 ± 1.5920.72 ± 1.450.21
IVD, mm-121.77 ± 2.0722.16 ± 1.7321.54 ± 1.5822.06 ± 1.400.091
CVD, mm-19.65 ± 3.08 10.00 ± 3.4410.07 ± 2.6910.17 ± 2.990.1211
cMean Foveal Thickness, μm244.50 ± 16.60221.9 ± 23.22222.4 ± 21.90222.7 ± 23.62< 0.0001
cFAZ, mm20.30 ± 0.110.27 ± 0.100.25 ± 0.100.28 ± 0.150.0022
cFVD, mm-120.01 ± 1.9819.47 ± 1.8418.66 ± 2.2319.28 ± 2.140.0006
cIVD, mm-121.20 ± 2.0720.73 ± 1.8821.74 ± 1.6920.51 ± 2.13< 0.0001
cCVD, mm-110.66 ± 4.379.66 ± 3.429.58 ± 3.259.686 ± 3.410.0256
Myopia rate, %77.149.427.541.8< 0.0001
Table 6 Reported superficial and deep foveal avascular zone areas calculated from optical coherence tomography angiography images, mean ± SD, mm2
Ref.
Region
Number of samples
FAZ, mm2
P value
Ghassemi et al[46], 2021Tehran Iran168 eyes from 54 subjects0.44 ± 0.78< 0.001
Hsu et al[39], 2019North Carolina135 eyes from 89 subjects0.35 ± 0.17< 0.001
Enrico Borrelli et al[52], 2019California77 eyes from 52 subjects0.261 ± 0.1490.0536
Kiziltoprak et al[43], 2020Turkey92 eyes0.28 ± 0.110.0278
İçel et al[41], 2020Turkey146 eyes0.30 ± 0.09< 0.001
Zhang et al[26], 2017China80 eyes0.290 ± 0.1090.029
Zhang et al[50], 2020China71 eyes0.29 ± 0.100.0041
Pérez-García et al[48], 2021Spain34 eyes0.25 ± 0.110.1183
Plaitano et al[45], 2022Italy206 eyes from 111 subjects0.27 ± 0.1060.0007
Fujiwara et al[42], 2017Japanese26 eyes0.33 ± 0.110.1533
Gómez-Ulla et al[38], 2019Spain20 eyes from 10 men0.298 ± 0.1080.1637
Yilmaz et al[1], 2017Istanbul45 eyes of 30 subjects0.280 ± 0.0970.0822
This reportQamdo, China347 eyes0.27 ± 0.120.0029